125 related articles for article (PubMed ID: 38406907)
61. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
[TBL] [Abstract][Full Text] [Related]
62. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
[TBL] [Abstract][Full Text] [Related]
63. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
64. Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.
Chen YK; Huang AH; Cheng PH; Yang SH; Lin LM
Clin Oral Investig; 2013 Apr; 17(3):921-32. PubMed ID: 22669485
[TBL] [Abstract][Full Text] [Related]
65. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
66. Immunohistochemical Expression of MCM-2 in Oral Epithelial Dysplasias.
Zakaria SH; Farag HA; Khater DS
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):509-513. PubMed ID: 26990745
[TBL] [Abstract][Full Text] [Related]
67. Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study.
Minardi D; Lucarini G; Filosa A; Zizzi A; Simonetti O; Offidani AM; d'Anzeo G; Di Primio R; Montironi R; Muzzonigro G
Cell Oncol (Dordr); 2012 Oct; 35(5):377-84. PubMed ID: 22972620
[TBL] [Abstract][Full Text] [Related]
68. Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder.
Lorenzo-Pouso AI; Lafuente-Ibáñez de Mendoza I; Pérez-Sayáns M; Pérez-Jardón A; Chamorro-Petronacci CM; Blanco-Carrión A; Aguirre-Urízar JM
J Oral Pathol Med; 2022 Aug; 51(7):585-593. PubMed ID: 35488780
[TBL] [Abstract][Full Text] [Related]
69. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
70. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
71. Differential Expression of Stem Cell Markers in Ocular Surface Squamous Neoplasia.
Mishra DK; Veena U; Kaliki S; Kethiri AR; Sangwan VS; Ali MH; Naik MN; Singh V
PLoS One; 2016; 11(9):e0161800. PubMed ID: 27584160
[TBL] [Abstract][Full Text] [Related]
72. Direct immunofluorescence testing results in cases of premalignant and malignant oral lesions.
Montague LJ; Bhattacharyya I; Islam MN; Cohen DM; Fitzpatrick SG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):675-83. PubMed ID: 25840514
[TBL] [Abstract][Full Text] [Related]
73. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
[TBL] [Abstract][Full Text] [Related]
74. Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma.
Yajima Y; Noma H; Furuya Y; Nomura T; Yamauchi T; Kasahara K; Hatada K; Takano M
Oral Oncol; 2004 Mar; 40(3):314-20. PubMed ID: 14747063
[TBL] [Abstract][Full Text] [Related]
75. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
76. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
[TBL] [Abstract][Full Text] [Related]
77. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
78. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
79. To evaluate eosinophilia (tissue eosinophilia, blood eosinophilia and tissue eosinophilia/blood eosinophilia ratio) in increasing grades/ severity of oral neoplastic lesions.
Kaur N; Zaheer S; Sangwan S; Ranga S
J Cancer Res Ther; 2023 Apr; 19(Supplement):S206-S211. PubMed ID: 37147998
[TBL] [Abstract][Full Text] [Related]
80. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.
Oh KY; Hong KO; Huh YS; Lee JI; Hong SD
J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
